Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Cowin Venture

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 76
Average round size
info
The average size of a deal this fund participated in
$16M
Portfolio companies 56
Rounds per year 5.07
Lead investments 14
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.25
Exits 3
Key employees 4
Stages of investment
Early Stage Venture
Private Equity
Seed

Areas of investment

  • Medical
  • Health Care
  • Biotechnology
  • Pharmaceutical
  • Manufacturing
Summary

In 2009 was created Cowin Venture, which is appeared as VC. The venture was found in Asia in China. The leading representative office of defined VC is situated in the Beijing.

The fund has no exact preference in some founders of portfolio startups. If startup sums 5+ of the founder, the chance for it to be financed is low. For fund there is a match between the location of its establishment and the land of its numerous investments - China. We can highlight the next thriving fund investment areas, such as Biotechnology, Interior Design. Among the most popular portfolio startups of the fund, we may highlight GeneCast Biotechnology, Thrive Earlier Detection, Linked-F. Moreover, a startup needs to be at the age of 2-3 years to get the investment from the fund.

The top activity for fund was in 2018. Despite it in 2019 the fund had an activity. The common things for fund are deals in the range of 50 - 100 millions dollars. Considering the real fund results, this VC is 23 percentage points more often commits exit comparing to other organizations. The fund is generally included in less than 2 deals every year. The top amount of exits for fund were in 2018. When the investment is from Cowin Venture the average startup value is 100-500 millions dollars. This Cowin Venture works on 15 percentage points less the average amount of lead investments comparing to the other organizations.

We also calculated 4 valuable employees in our database.

The typical case for the fund is to invest in rounds with 3-4 participants. Despite the Cowin Venture, startups are often financed by Matrix Partners China, SBCVC, Northern Light Venture Capital. The meaningful sponsors for the fund in investment in the same round are Matrix Partners China, SBCVC, ZSVC. In the next rounds fund is usually obtained by Matrix Partners China, SBCVC, ZSVC.

Read more

Funds with similar focus

Funds from China
Funds with similar focus located in China:
Funds with the same geo focus
Funds with similar geography of portfolio companies:
Funds doing lead investments
Funds with similar focus acting as lead investors:

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Xingmu

20 Mar 2024 Hefei, Anhui, China

ZWI Therapeutics

Health Care
Medical
$10M24 Jan 2024 Cambridge, Massachusetts, United States

Myrobalan Therapeutics

Biotechnology
Health Care
Therapeutics
$24M10 Jan 2024 Medford, Massachusetts, United States

Lengchen Technology

Advanced Materials
Laser
Manufacturing
10 Nov 2023 -

Gongyan Tuoxin

Electronics
Manufacturing
Optical Communication
Semiconductor
$15M27 Sep 2023 Suzhou, Jiangsu, China

Makino micro

Electronics
Manufacturing
Semiconductor
$15M10 Apr 2023 Shenzhen, Guangdong, China

Yimai Silicon

Electronics
Packaging Services
Semiconductor
07 Apr 2023 Suzhou, Jiangsu, China

BioTroy Therapeutics

Health Care
Health Diagnostics
Medical
$15M07 Mar 2023 China, China

Immorna

Biotechnology
Health Care
Medical
$13M27 Feb 2023 Hangzhou, Zhejiang, China

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Cowin Venture?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 76
Average round size 16M
Rounds per year 5.07
Peak activity year 2021
Lead investments 14
Follow on index 0.25
Exits 3
Group Appearance index 0.82

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

Xingmu

20 Mar 2024 Hefei, Anhui, China

ZWI Therapeutics

Health Care
Medical
$10M24 Jan 2024 Cambridge, Massachusetts, United States

Myrobalan Therapeutics

Biotechnology
Health Care
Therapeutics
$24M10 Jan 2024 Medford, Massachusetts, United States

Lengchen Technology

Advanced Materials
Laser
Manufacturing
10 Nov 2023 -

Gongyan Tuoxin

Electronics
Manufacturing
Optical Communication
Semiconductor
$15M27 Sep 2023 Suzhou, Jiangsu, China

Makino micro

Electronics
Manufacturing
Semiconductor
$15M10 Apr 2023 Shenzhen, Guangdong, China

Yimai Silicon

Electronics
Packaging Services
Semiconductor
07 Apr 2023 Suzhou, Jiangsu, China

BioTroy Therapeutics

Health Care
Health Diagnostics
Medical
$15M07 Mar 2023 China, China

Immorna

Biotechnology
Health Care
Medical
$13M27 Feb 2023 Hangzhou, Zhejiang, China
Crunchbase icon

Content report

The following text will be sent to our editors: